1. Home
  2. PBM vs BFRI Comparison

PBM vs BFRI Comparison

Compare PBM & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • BFRI
  • Stock Information
  • Founded
  • PBM 1994
  • BFRI 1997
  • Country
  • PBM Canada
  • BFRI United States
  • Employees
  • PBM N/A
  • BFRI N/A
  • Industry
  • PBM
  • BFRI Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBM
  • BFRI Health Care
  • Exchange
  • PBM NYSE
  • BFRI Nasdaq
  • Market Cap
  • PBM 5.3M
  • BFRI 6.2M
  • IPO Year
  • PBM N/A
  • BFRI 2021
  • Fundamental
  • Price
  • PBM $1.30
  • BFRI $1.11
  • Analyst Decision
  • PBM
  • BFRI Strong Buy
  • Analyst Count
  • PBM 0
  • BFRI 1
  • Target Price
  • PBM N/A
  • BFRI $7.00
  • AVG Volume (30 Days)
  • PBM 367.3K
  • BFRI 158.3K
  • Earning Date
  • PBM 02-02-2025
  • BFRI 03-14-2025
  • Dividend Yield
  • PBM N/A
  • BFRI N/A
  • EPS Growth
  • PBM N/A
  • BFRI N/A
  • EPS
  • PBM N/A
  • BFRI N/A
  • Revenue
  • PBM N/A
  • BFRI $35,358,000.00
  • Revenue This Year
  • PBM N/A
  • BFRI $17.69
  • Revenue Next Year
  • PBM N/A
  • BFRI $19.71
  • P/E Ratio
  • PBM N/A
  • BFRI N/A
  • Revenue Growth
  • PBM N/A
  • BFRI 5.17
  • 52 Week Low
  • PBM $1.15
  • BFRI $0.65
  • 52 Week High
  • PBM $323.25
  • BFRI $2.43
  • Technical
  • Relative Strength Index (RSI)
  • PBM 38.56
  • BFRI 49.87
  • Support Level
  • PBM $1.15
  • BFRI $1.06
  • Resistance Level
  • PBM $1.47
  • BFRI $1.16
  • Average True Range (ATR)
  • PBM 0.13
  • BFRI 0.07
  • MACD
  • PBM 0.04
  • BFRI -0.00
  • Stochastic Oscillator
  • PBM 34.09
  • BFRI 55.00

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

Share on Social Networks: